Trump announces emergency authorisation of plasma for coronavirus patients

Making a "breakthrough" announcement on Sunday, US President Donald Trump said that the FDA [US Food and Drug Administration] has authorised the emergency use of convalescent plasma for the treatment of Covid-19 patients -- a technique that uses antibodies from coronavirus recovered patients to treat the ones infected with the virus.

"Today, I am pleased to make a truly historic announcement in our battle against China virus, that will save countless lives. The FDA has issued an emergency use authorisation for a treatment known as convalescent plasma," Donald Trump said.